All In Biotech

Drug Trial Radar · NCT07595549

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF ONCE-MONTHLY PF-08653944 IN ADULTS WITH OVERWEIGHT OR OBESITY (VESPER-6)

Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 954 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

954

Planned (sponsor's estimate)

Start

Jun 10, 2026

Primary completion

May 4, 2028

Study completion Jun 21, 2028

Sponsor

Lead sponsor
PfizerPfizer (PFE)
Sponsor type
Industry
First posted
May 19, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this clinical study is to learn about the effects and safety of berobenatide (PF-08653944). This may help people with overweight or obesity lose weight. People in this study may also have type 2 diabetes. About 950 adults will be in this study. Berobenatide will be compared to a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. Berobenatide or placebo is given by a shot under the skin in the belly area. The objective of the study is to compare the experiences of people receiving berobenatide to those of the people who do not to assess if the study medicine is effective and safe. People will take part in this study for about 20 months. During this time, they will have about 15 study visits at the site. They will also have 2 study visits over the phone.

Conditions

  • Obesity
  • Overweight and/or Obesity
  • Overweight

Interventions

  • PF-08653944Drug

    By Subcutaneous Injection

  • PlaceboOther

    By Subcutaneous Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percent change from baseline in body weightTime frame: Baseline, Week 72

Locations

80 sites in 11 countries. Site status is shown where the registry gives one.

  • San Fernando Valley Health Institute

    Canoga Park, California · Recruiting

  • Headlands Research California, LLC

    Escondido, California · Recruiting

  • ImmuniMet, LLC

    Modesto, California · Recruiting

  • Clinical Trials Research

    Sacramento, California · Recruiting

  • University Clinical Investigators, Inc.

    Tustin, California · Recruiting

  • Diablo Clinical Research, Inc.

    Walnut Creek, California · Recruiting

  • Southern California Retina Specialists

    West Hills, California · Recruiting

  • Nature Coast Clinical Research

    Crystal River, Florida · Recruiting

  • West Coast Eye Institute

    Lecanto, Florida · Recruiting

  • South Broward Research

    Miramar, Florida · Recruiting

  • Suncoast Clinical Research, Inc.

    New Port Richey, Florida · Active not recruiting

  • West Coast Medical Associates

    New Port Richey, Florida · Active not recruiting

  • Center for Diabetes, Obesity and Metabolism Inc

    Pembroke Pines, Florida · Recruiting

  • Cedar Crosse Research Center

    Chicago, Illinois · Recruiting

  • Northwestern University

    Chicago, Illinois · Recruiting

  • Endeavor Health - Family Medicine Administration

    Evanston, Illinois · Recruiting

  • Endeavor Health- Endocrinology Research

    Skokie, Illinois · Recruiting

  • MediSphere Medical Research Center, LLC

    Evansville, Indiana · Recruiting

  • Monroe Biomedical Research

    Louisville, Kentucky · Active not recruiting

  • Louisville Retina, PLLC

    Louisville, Kentucky · Active not recruiting

  • Ascension Saint Agnes Heart Care

    Baltimore, Maryland · Recruiting

  • Aa Mrc Llc

    Flint, Michigan · Recruiting

  • University Of Nebraska Medical Center

    Omaha, Nebraska · Recruiting

  • Albuquerque Clinical Trials, Inc.

    Albuquerque, New Mexico · Recruiting

  • Weill Cornell Medicine - Comprehensive Weight Control Center

    New York, New York · Recruiting

  • Rochester Clinical Research, LLC

    Rochester, New York · Active not recruiting

  • Medication Management, LLC

    Greensboro, North Carolina · Recruiting

  • Accellacare - Wilmington

    Wilmington, North Carolina · Recruiting

  • Jeffrey Coleman, OD

    Wilmington, North Carolina · Recruiting

  • Midwest Eye Center

    Cincinnati, Ohio · Recruiting

  • Velocity Clinical Research, Mt. Auburn

    Cincinnati, Ohio · Recruiting

  • PlanIt Research, LLC (Monitoring Room)

    Houston, Texas · Recruiting

  • PlanIt Research, LLC

    Houston, Texas · Recruiting

  • VIP Trials

    San Antonio, Texas · Recruiting

  • York Clinical Research, LLC

    Norfolk, Virginia · Recruiting

  • CEPIC - Centro Paulista de Investigação Clínica

    São Paulo, Brazil · Recruiting

  • Hospital das Clínicas da Faculdade de Medicina da USP

    São Paulo, Brazil · Recruiting

  • Associação de Amparo à Saúde, Ensino e Pesquisa

    Brasília, Federal District, Brazil · Recruiting

  • Saraiva & Berlinger Ltda EPP Instituto de Pesquisa Clínica de Campinas

    Campinas, São Paulo, Brazil · Recruiting

  • Fundação Faculdade Regional de Medicina de São José do Rio Preto

    São José do Rio Preto, São Paulo, Brazil · Recruiting

Showing 40 of 80 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.